Having a preexisting autoimmune disease is an independent risk factor for poor outcomes with myelodysplastic syndrome (MDS), according to a study published in the June issue of Clinical Immunology.
Continue Reading this article here
Autoimmune disease linked to poor outcomes with myelodysplastic syndrome
